cas 28875-17-4|| where to buy N-Boc-L-alanine Methyl Ester

Nom du produit:N-Boc-L-alanine Methyl Ester

IUPAC Name:methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}propanoate

Unité d'emballage	Stock disponible	Prix($)
CM119523-25g	1-2 Weeks	Ȏŉ
CM119523-100g	3-4 Weeks	ǵŉƄ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 28875-17-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:28875-17-4; Formule moléculaire:C9H17NO4; Point de fusion:-; Code SMILES:C[C@@H](C(OC)=O)NC(OC(C)(C)C)=O; Densité:

: Numéro de catalogue:CM119523; Poids moléculaire:203.24; Point d'ébullition:; N° Mdl:MFCD00038513; Stockage:

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: PF-06648671; The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).